Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 23

1745P - Why do adult patients with cancer abandon treatment in India? A nationwide qualitative study to understand the perspectives of healthcare workers

Date

21 Oct 2023

Session

Poster session 23

Topics

Cancer Prevention;  Cancer Research;  Psychosocial Aspects of Cancer

Tumour Site

Presenters

Reshma Ayiraveetil

Citation

Annals of Oncology (2023) 34 (suppl_2): S925-S953. 10.1016/S0923-7534(23)01945-2

Authors

R. Ayiraveetil1, M. Chittem2, S. Lakshminarayanan3, S. Veeraiah4, P. Penumadu5, J. Pandjatcharam6, S. Kayal7, B. Dubashi8, P. Ganesan1

Author affiliations

  • 1 Medical Oncology, JIPMER - Jawaharlal Institute of Postgraduate Medical Education and Research, 605006 - Puducherry/IN
  • 2 Liberal Arts, IIT-Indian Institute of Technology Hyderabad, 502285 - Hyderabad/IN
  • 3 Preventive And Social Medicine, Jawaharlal institute of postgraduate medical education and research, 605006 - Puducherry/IN
  • 4 Psycho-oncology, Cancer Institute (WIA), 600036 - Chennai/IN
  • 5 Surgical Oncology Department, JIPMER - Jawaharlal Institute of Postgraduate Medical Education and Research, 605006 - Puducherry/IN
  • 6 Radiation Oncology Department, JIPMER - Jawaharlal Institute of Postgraduate Medical Education and Research, 605006 - Puducherry/IN
  • 7 Medical Oncology Department, JIPMER - Jawaharlal Institute of Postgraduate Medical Education and Research, 605006 - Puducherry/IN
  • 8 Medical Oncology Dept., JIPMER - Jawaharlal Institute of Postgraduate Medical Education and Research, 605006 - Puducherry/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1745P

Background

Treatment abandonment (TA) is a major challenge in cancer care leading to poor outcomes and wastage of resources. Reasons for TA are multi-factorial and country specific. Understanding these complexities is the first step toward developing effective strategies for the prevention of TA. Insights and experiences of healthcare workers (HCWs) can provide valuable information about the factors contributing to TA; hence we conducted a qualitative study to understand the issues.

Methods

The participants were purposively selected, experienced HCWs (N=30) treating cancer patients from high-volume cancer centres nationwide. In-depth interviews (semi-structured, open-ended) were conducted by a person trained and experienced in qualitative interviews to understand the perspectives of HCWs on TA among adult cancer patients. We used the grounded theory approach to thematically analyze the data using inductive analysis.

Results

The HCWs (oncologists=17, nurses=6, psycho-oncologists=3, counselors=4) were selected from 9 states of India representing all geographical regions and working in both private (paid services, N= 14) and government (free services, N=16) sectors. The average duration of the interview was 30 minutes, and the reasons for TA perceived by the HCWs were classified under 6 themes: 1) Socio-demographic, 2) Patient-specific, 3) Clinical, 4) Psychological, 5) Health system related, and 6) Economic factors. Catastrophic health expenditure, direct medical and/or non-medical costs, indirect medical costs, poor socio-economic status, lack of specific knowledge about disease and treatment, poor patient-provider communication, accessibility, psychological distress, and toxicities of treatment were the common reasons for TA cited by the HCWs.

Conclusions

The study is one of the first studies reporting on HCWs’ perspective on TA among cancer patients in India. In addition to well-known socio-economic factors, this study identified important themes such as lacunae in communication and psychological issues (e.g., distress) causing TA. The results of this study will help plan quantitative research into the complex issues of TA and interventions to counter the problem.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

P. Ganesan.

Funding

Indian Council of Medical Research-ICMR, New Delhi, India.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.